Featured resources
No Surprises: PharPoint’s Transparent Approach to Changes in Scope
How does your CRO handle changes in scope (CIS)? Learn more about PharPoint's transparent process ...
Evaluating Quality Culture in Clinical Research
Evaluating Quality Culture in Clinical Research: Beyond the Buzzword While it’s one thing to discuss a culture of quality in clinical research, it’s much more complicated to make it a reality – embedded into the way teams think, act, and make decisions across an entire organization. This echoes timeless guidance from W. Edwards Deming, an influential leader and business theorist who helped spark the quality revolution in the 1980s: quality isn’t achieved through inspection or slogans – it’s built into every process, every decision, and every relationship.We spoke with Melisa Williamson, PharPoint’s Director of Quality Assurance (QA) to explore what a ...
Browse all resources
75+ free resources from PharPoint | Insight, checklists, & more
Operationalizing ICH E6(R3) and QbD with a Quality Assurance Consultant
How can a QA consultant help your team fully adopt QbD? ...
Evaluating Quality Culture in Clinical Research
Evaluating Quality Culture in Clinical Research: Beyond the Buzzword While it’s one thing to discuss a culture of quality in ...
Why Deming’s Out of the Crisis Still Shapes My Approach to Clinical Quality
QA Director Melisa Williamson talks about "Out of the Crisis" by W. Edwards Deming and how it has influenced her ...
Solving Data Management Challenges with Strategic CRO Oversight
Explore three common findings from a data management consultant who has experience performing DM CRO oversight ...
CRO Study Team Continuity and Transparency
Will you actually be working with the team a CRO introduces you to in early discussions? ...
Case Study: Proactive Risk Mitigation in Early Phase Oncology
This case study highlights how the PharPoint team supported a Phase 1 FIH oncology study that completed LPLV and database ...
Meet Melisa Williamson, Director of Quality Assurance
Get to know PharPoint's new Director of Quality Assurance, Melisa Williamson, with a quick Q&A ...
Considerations for Sponsors Conducting Protocol Feasibility and Review
A comprehensive protocol review requires a multi-disciplinary group. Who should be included and what should this group be looking for? ...
Clinical Trial Budget Risks: The Hidden Cost of Protocol Amendments
Protocol amendments are increasingly common. What are they costing you? ...
